Saskatoon

Saskatoon has emerged as a premier global life sciences hub, distinguished by its unique integration of human and animal health research through the "One Health" lens.

At the center of this ecosystem is the University of Saskatchewan, which hosts world-class facilities like the Canadian Light Source synchrotron and VIDO (Vaccine and Infectious Disease Organization), Canada’s Centre for Pandemic Research.

Saskatoon is internationally recognized for its biotechnology prowess, particularly in vaccine development, infectious disease research and agricultural biotechnology.

The city’s pharmaceutical sector is bolstered by specialized manufacturing capabilities and a growing pipeline of biopharma startups specializing in protein engineering.

Innovation Place, one of North America's most successful university-related technology parks, fosters healthcare innovation by providing specialized lab spaces for medical device startups and digital health firms.

Academic research in Saskatoon is highly collaborative, bridging the gap between bench-side discovery and commercialization through the Innovation & Science Fund.

Global investors are increasingly drawn to the region’s clinical trial infrastructure and the Saskatchewan Health Authority’s commitment to adopting cutting-edge technologies.

The ecosystem’s strength in nuclear medicine, supported by the Saskatchewan Centre for Cyclotron Sciences, is driving breakthroughs in diagnostic imaging and cancer treatment.

By leveraging a highly skilled workforce and competitive R&D tax incentives, Saskatoon is rapidly becoming a destination of choice for life sciences investment and international partnerships.

This thriving cluster ensures that Saskatoon remains at the forefront of solving global health challenges through sustainable, multidisciplinary innovation.